National Institute for Health and Clinical Excellence (NICE)
NICE recommends treatment options for severe pregnancy sickness in new draft guidance
Nausea and vomiting, often referred to as morning sickness, is common in pregnancy. Close to 80% of pregnant women experience these symptoms, with most conditions improving or stopping completely by around 16 to 20 weeks
In many cases, at-home remedies such as ginger can help to alleviate symptoms, but in a small percentage of pregnant women, the condition can be more serious. Between 0.3 and 3.6% of pregnant women experience excessive nausea and vomiting known as hyperemesis gravidarum, which can sometimes lead to hospitalisation.
In draft guidance published today, NICE recommends treatment options for hyperemesis gravidarum for the first time.
New recommendations advise the use of pharmacological antiemetics (known as anti-sickness medicines), acupressure, and intravenous fluids to treat these extreme cases of nausea and vomiting in pregnancy, in line with guidance from the Royal College of Obstetricians and Gynaecologists.
Dr Paul Chrisp, director of the Centre for Guidelines at NICE, said: “While non-pharmacological treatments may help the majority of women experiencing nausea and vomiting during pregnancy, hyperemesis gravidarum can be extremely serious, and it is essential that effective treatment options are available.
“It is our hope that this guidance will help inform clinicians of the value of treatments like antiemetics and acupressure, and enable them to provide care that keeps women safe and healthy throughout their pregnancy.”
Dr Edward Morris, President at the Royal College of Obstetricians and Gynaecologists, said: “We’re very pleased that NICE have updated their guidance on antenatal care and have included the debilitating condition hyperemesis gravidarum. This new guidance now reflects and is consistent with the guidance produced by the RCOG in 2016.
“We would encourage all hospitals to implement and follow these guidelines so that women are provided with high quality care throughout their pregnancy. It’s important pregnant women feel listened to and are offered regular check-ups, information and support throughout. We know the pandemic has added a layer of anxiety for many women who are navigating pregnancy under difficult restrictions, and we support a consistent approach to care across all Trusts.”
The new draft guideline replaces the recommendations from NICE’s guidance on antenatal care, published in 2008, and aims to improve consistency of care across the country. The recommendations are based on evidence collected prior to the COVID-19 pandemic.
The update offers practical advice on the care of healthy women and their babies during pregnancy. It aims to ensure that women are offered regular check-ups, information and support, and includes recommendations on a range of topics from monitoring foetal growth to sleep positions to avoid during pregnancy.
Although evidence supports the benefits of new draft recommendations, such as involving partners in antenatal appointments, the committee recognises that alternative arrangements may need to be made throughout the COVID-19 pandemic. The guidance suggests that health care practitioners consider virtual appointments and classes, which may be especially beneficial while government restrictions are in place.
Dr Chrisp added: “We are aware that the sensitivities of the pandemic mean that not all of the new recommendations in this update can be supported at the present time, but our hope is that alternatives may be considered where appropriate.”
The draft guidance is out for public consultation until 24 March 2021. Find the draft and participate in the consultation here.
Latest News from
National Institute for Health and Clinical Excellence (NICE)
NICE recommends range of effective treatments for people with chronic primary pain and calls on healthcare professionals to recognise and treat a person’s pain as valid and unique to them07/04/2021 13:20:00
People with chronic primary pain should be offered a range of treatments to help them manage their condition, NICE has said in its guideline on the assessment and management of chronic pain published today (7 April)
Starting with the end in mind - the Innovative Licensing and Access Pathway29/03/2021 16:15:00
Blog posted by: Nick Crabb and Meindert Boysen, NICE's members on the ILAP Steering Group, 26 March 2021.
NICE publishes single guideline for managing COVID-1924/03/2021 11:15:00
One year on from the first national lockdown, NICE yesterday (23 March) published a single guideline for the management of COVID-19 in children and adults.
Triple therapy recommended by NICE for patients with multiple myeloma23/03/2021 14:15:00
The therapy has been recommended after a confidential discount was agreed between NHS England and the drug manufacturer Amgen.
Unpaid carers should be offered advice and support, says NICE19/03/2021 15:25:00
NICE has today published a new quality standard aimed at improving the wellbeing of adults who provide unpaid care for people over 16 years old
Ovarian cancer patients to have NICE-approved drug combination option on Cancer Drugs Fund19/03/2021 12:20:00
A potentially life-extending drug combination for some people with advanced, high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer will now be available on the Cancer Drugs Fund (CDF), following its approval by NICE in draft guidance published today
Chemotherapy-free treatment option to be offered to patients with England’s most common leukaemia19/03/2021 11:15:00
Acalabrutinib, taken as a twice daily tablet, is recommended as an option for adults with untreated chronic lymphocytic leukaemia.
NICE approves life-changing gene therapy for treating spinal muscular atrophy09/03/2021 16:15:00
A new and potentially curative one-off gene therapy for babies with the rare genetic disorder spinal muscular atrophy (SMA) is set to become the most expensive treatment ever approved by NICE.
Children and young people need accurate, accessible information about their healthcare05/03/2021 11:25:00
New draft guidance from NICE published today recommends ensuring children and young people are fully informed about their health so that they are empowered to take an active role in their healthcare